Role of the microtubule-targeting drug vinflunine on cell-cell adhesions in bladder epithelial tumour cells

Luís Antón Aparicio(Universidade da Coruña), Angélica Figueroa(Universidade da Coruña), M. Blanco(Hospital Universitari de Girona Doctor Josep Trueta), María F. Carrera Rodríguez(Complexo Hospitalario Universitario A Coruña), Manuel Valladares(American Society of Clinical Oncology), Mar Haz‐Conde(Complexo Hospitalario Universitario A Coruña), Raquel Castosa(Universidade da Coruña)
BMC Cancer
July 10, 2014
10.1186/1471-2407-14-507
Cited by 22

Related Papers

Cancer drug resistance induced by EMT: novel therapeutic strategies
|Archives of Toxicology|2021|220
First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study
|The Oncologist|2012|213
The clinical–DWI mismatch
|Neurology|2004|207
Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy
|International Journal of Endocrinology|2010|175
Irinotecan in Combination With Fluorouracil in a 48-Hour Continuous Infusion As First-Line Chemotherapy for Elderly Patients With Metastatic Colorectal Cancer: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study
|Journal of Clinical Oncology|2005|98